Skip to Main Content
The first stop for professional medicines advice

Biosimilar and key generic medicines – September 2025 update

Event 11 September 2025Location Online via WebEx at 13:00-14:00
Topics: BiosimilarsPast Events

An update about biosimilar and key generic medicines to support system mobilisation.

Contents
  1. Date
  2. Location
  3. About the event
    1. Why it’s important
    2. What was covered
  5. Speakers
    1. Non-SPS speakers
    2. SPS Speakers
  7. Contact us
  8. Update history

Date

11 September 2025

Location

Online via WebEx at 13:00-14:00

About the event

Speakers from NHS England and NHS SPS provided insights to support planning and implementation of upcoming biosimilar and key generic medicines. This webinar included an overview about how patents work with respect to medicines and the factors influencing the availability of generic and biosimilar medicines after loss of exclusivity.  

There was an opportunity to ask questions from NHSE and NHS SPS colleagues.

This webinar was intended for NHS procurement and clinical teams who will be implementing upcoming biosimilar and high value generic medicines. It was not  recorded as some information is commercially confidential and subject to change.

Why it’s important

Implementation of biosimilar and key generic medicines requires collaborative working across the system. The use of biological medicines, including biosimilars, in clinical practice is expanding.  

Timely implementation and use of biosimilar and key generic medicines offers the NHS opportunities to deliver better value for certain conditions.

What was covered

  • Updated information to support system mobilisation for aflibercept and golimumab biosimilars just prior to the MPSC frameworks starting, and planning for denosumab and other upcoming biosimilar and key generic medicines.
  • An overview of how patents work with respect to medicines and the factors influencing the availability of generic and biosimilar medicines after loss of exclusivity. 
  • A question and answer session with NHSE and NHS SPS colleagues.

Speakers

A range of speakers from SPS and other organisations will run this event.

Non-SPS speakers

Jeff Gibson

Senior strategic category manager, Medicines Value and Access; NHS England

Shu Yi Tan

Pharmacist (Pharmacy & Clinical Support Team), Medicines Value & Access; NHS England

SPS Speakers

Learn more about SPS team members who are speaking.

Contact us

Please contact the admin team if you have any questions.

Update history

  1. Registration block removed. Changed to past tense.
  1. NHSE speaker added
  1. Additional speaker added
  1. Event date removed from summary
  1. What will be covered changed to bullet points
  1. Published

Print this page